United Therapeutics Corp

NMS : UTHR
Pharmaceuticals
Silver Spring MD
Revenue (US$ Millions)$1,289
Revenue Growth (%)15.36%
Net Income (Millions)$340
Common Shares Outstanding (Millions)$47
Earnings per Share$6.28
Price To Earnings Ratio19.29
Total Equity (Millions)$1,266
Profit Margin 126.39%
Return on Equity26.07%
Long Term Debt (US$ Millions)N/A
Debt To Equity Ratio (%)N/A
Market Capitalization (US$ Millions)$6,100
Total Assets (US$ Millions)$1,884
Return on Assets (%)16.29
Current Assets (US$ Millions)$974
Inventories (US$ Millions)$67
Current Liabilities (US$ Millions)$504
Cost of Goods Sold (US$ Millions)$126
Asset Turnover0.68
Inventory Turnover2.2